Mohit Bansal analyst WELLS FARGO

Currently out of the existing stock ratings of Mohit Bansal, 118 are a BUY (62.11%), 68 are a HOLD (35.79%), 4 are a SELL (2.11%).

Mohit Bansal

Work Performance Price Targets & Ratings Chart

Analyst Mohit Bansal works at WELLS FARGO with a stock forecast success ratio of 65.73% fulfilled within 176.75 days on average.

Mohit Bansal’s has documented 367 price targets and ratings displayed on 32 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on MRK, Merck mpany at 27-Mar-2024.

Wall Street Analyst Mohit Bansal

Analyst best performing recommendations are on KRTX (KARUNA THERAPEUTICS).
The best stock recommendation documented was for KRTX (KARUNA THERAPEUTICS) at 11/18/2019. The price target of $115 was fulfilled within 1 day with a profit of $19 (19.79%) receiving and performance score of 197.92.

Average potential price target upside

AGIO Agios Pharm ALXN Alexion Pharmaceuticals AMGN Amgen BIIB Biogen BMRN Biomarin Pharmaceutical CALA Calithera Biosciences CHRS Coherus BioSciences CTMX CytomX Therapeutics EPZM Epizyme FOLD Amicus Therapeutics GILD Gilead Sciences LLY Eli Lilly and Company MYOK MyoKardia MYOV Myovant Sciences Ltd PFE Pfizer RDUS Schnitzer Steel Industries REGN Regeneron Pharmaceuticals VRTX Vertex Pharmaceuticals ABBV AbbVie BMY Bristol-Myers Squibb Company KRTX Karuna Therapeutics MRK Merck mpany SNSE Sensei Biotherapeutics STTK Shattuck Labs  NBIX Neurocrine Biosciences BOLD Audentes Therapeutics CERE Cerevel Therapeutics Holdings HALO Halozyme Therapeutics ONCE Spark Therapeutics KDNY Chinook Therapeutics IRWD Ironwood Pharmaceuticals TVTX Travere Therapeutics

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

30

$2.3 (8.30%)

32

1 months 21 days ago

3/3 (100%)

$-2.99 (-9.06%)

224

Hold

28

$0.3 (1.08%)

32

5 months 10 days ago

6/6 (100%)

$5.51 (24.50%)

192

Buy

42

$14.3 (51.62%)

67

9 months 17 days ago

5/12 (41.67%)

$13.87 (49.31%)

213

Buy

38

$10.3 (37.18%)

40

9 months 17 days ago

0/4 (0%)

$9.87 (35.09%)

Buy

37

$9.3 (33.57%)

33

1 years 8 months 8 days ago

6/11 (54.55%)

$7.26 (24.41%)

69

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Mohit Bansal is most bullish on?

Potential upside of $135.78 has been obtained for VRTX (VERTEX PHARMACEUTICALS)

Which stock is Mohit Bansal is most reserved on?

Potential downside of -$0.1 has been obtained for BMY (BRISTOL-MYERS SQUIBB COMPANY)

What Year was the first public recommendation made by Mohit Bansal?

On 2014

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?